Journal Title：Toxicology In Vitro

Toxicology in Vitro publishes original research papers and reviews on the application and use of in vitro systems for assessing or predicting the toxic effects of chemicals and elucidating their mechanisms of action. These in vitro techniques include utilizing cell or tissue cultures, isolated cells, tissue slices, subcellular fractions, transgenic cell cultures, and cells from transgenic organisms, as well as in silico modelling. The Journal will focus on investigations that involve the development and validation of new in vitro methods, e.g. for prediction of toxic effects based on traditional and in silico modelling; on the use of methods in high-throughput toxicology and pharmacology; elucidation of mechanisms of toxic action; the application of genomics, transcriptomics and proteomics in toxicology, as well as on comparative studies that characterise the relationship between in vitro and in vivo findings. The Journal strongly encourages the submission of manuscripts that focus on the development of in vitro methods, their practical applications and regulatory use (e.g. in the areas of food components cosmetics, pharmaceuticals, pesticides, and industrial chemicals). Toxicology in Vitro discourages papers that record reporting on toxicological effects from materials, such as plant extracts or herbal medicines, that have not been chemically characterized.

《體外毒理學》發(fā)表原創(chuàng)研究論文和評論，內(nèi)容涉及體外系統(tǒng)在評估或預測化學物質(zhì)毒性作用和闡明其作用機制方面的應(yīng)用和使用。這些體外技術(shù)包括利用細胞或組織培養(yǎng)物、分離細胞、組織切片、亞細胞部分、轉(zhuǎn)基因細胞培養(yǎng)物和轉(zhuǎn)基因生物細胞以及計算機模擬。該期刊將重點關(guān)注涉及開發(fā)和驗證新體外方法的研究，例如基于傳統(tǒng)和計算機模擬預測毒性作用；高通量毒理學和藥理學方法的使用；毒性作用機制的闡明；基因組學、轉(zhuǎn)錄組學和蛋白質(zhì)組學在毒理學中的應(yīng)用，以及描述體外和體內(nèi)發(fā)現(xiàn)之間關(guān)系的比較研究。本期刊強烈鼓勵投稿關(guān)注體外方法的開發(fā)、其實際應(yīng)用和監(jiān)管用途（例如在食品成分化妝品、藥品、農(nóng)藥和工業(yè)化學品領(lǐng)域）。《體外毒理學》不鼓勵投稿記錄未經(jīng)化學鑒定的材料（如植物提取物或草藥）的毒理學效應(yīng)報告的論文。

Toxicology In Vitro創(chuàng)刊于1987年，由Elsevier Ltd出版商出版，收稿方向涵蓋醫(yī)學 - 毒理學全領(lǐng)域，此刊是中等級別的SCI期刊，所以過審相對來講不是特別難，但是該刊專業(yè)認可度不錯，仍然是一本值得選擇的SCI期刊 。平均審稿速度 約2.0個月 約10.9周，影響因子指數(shù)2.6，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。